Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Depression 4Neoplasms 3Anxiety Disorders 3Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Hematopoietic and Lymphatic System Neoplasm 1Gastrointestinal Neoplasms 1Depressive Disorder, Major 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Specimen Handling 4Fluorouracil 4Bevacizumab 4fludarabine 3aldesleukin 3Radiosurgery 3Gemcitabine 3Endoscopic Mucosal Resection 3Cyclophosphamide 3Cetuximab 3130-nm albumin-bound paclitaxel 3Surveys and Questionnaires 2Sunitinib 2Pemetrexed 2Oxaliplatin 2Leucovorin 2IDRX-42 2Folfox protocol 2trastuzumab deruxtecan 1tislelizumab 1sodium thiosulfate 1sodium propionate 1semaglutide 1repotrectinib 1plecanatide 1pembrolizumab 1patritumab deruxtecan 1palbociclib 1linaclotide 1isosorbide-5-mononitrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Psilocybin × 90 days × Clear all
NCT05220046 2026-05-06

Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers

University of Nebraska

Phase 1 Active not recruiting
24 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡